NFKB1 and pancreatitis: 2018). A recent study showed that administration of SSa attenuated hyperlipidaemic pancreatitis in rats by improving lipid metabolism effectively characterized by a decrease in total cholesterol and triglycerides in serum. In addition, it significantly decreased the levels of pancreatic enzymes (MPO, amylase and lipase) and reduced proinflammatory cytokines (TNF‐α, IL-1β and IL-6) release by suppressing the NF-κB signalling pathway and promoting the expression of peroxisome proliferator-activated receptor-γ (PPAR-γ) (Feng et al. 2019).